Ottawa Told to Hurry Domestic Vaccine Funding Amid China Delays

In this handout photo released by the University of Oxford, a volunteer participates in the CCP virus vaccine trial in Oxford, England, on July 7, 2020. The Canadian Press/AP-University of Oxford via AP

OTTAWA—The Trudeau government is being pressed to approve funding for a made-in-Canada COVID-19 vaccine to lessen the risk Canadians will have to line up and wait on a foreign-made pandemic cure.

For instance, health-care professionals have written to Innovation Minister Navdeep Bains to urge him make up his mind on a proposal submitted in April by Providence Therapeutics of Toronto. The company is seeking $35 million to establish whether its vaccine is effective in humans after successful animal trials.